HCA Healthcare Inc (NYSE:HCA) SVP Victor L. Campbell sold 28,084 shares of the company’s stock in a transaction dated Monday, February 11th. The shares were sold at an average price of $138.97, for a total transaction of $3,902,833.48. Following the completion of the transaction, the senior vice president now owns 231,493 shares in the company, valued at $32,170,582.21. The transaction was disclosed in a filing with the SEC, which is available at this link.
Shares of HCA stock traded down $0.87 during trading hours on Monday, hitting $138.66. 1,008,119 shares of the company were exchanged, compared to its average volume of 1,587,261. HCA Healthcare Inc has a 1 year low of $93.03 and a 1 year high of $147.42. The firm has a market cap of $48.02 billion, a P/E ratio of 14.19, a PEG ratio of 1.16 and a beta of 0.80.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, January 29th. The company reported $2.99 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.59 by $0.40. HCA Healthcare had a net margin of 8.11% and a negative return on equity of 91.25%. The firm had revenue of $12.27 billion for the quarter, compared to analyst estimates of $12.10 billion. During the same quarter last year, the firm posted $2.12 earnings per share. HCA Healthcare’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, equities analysts expect that HCA Healthcare Inc will post 10.02 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 29th. Investors of record on Friday, March 1st will be issued a $0.40 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.35. The ex-dividend date of this dividend is Thursday, February 28th. This represents a $1.60 annualized dividend and a yield of 1.15%. HCA Healthcare’s dividend payout ratio (DPR) is presently 14.33%.
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Advisor Group Inc. raised its holdings in HCA Healthcare by 30.2% in the fourth quarter. Advisor Group Inc. now owns 10,296 shares of the company’s stock valued at $1,282,000 after buying an additional 2,389 shares during the period. Raymond James Financial Services Advisors Inc. raised its holdings in HCA Healthcare by 4.8% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 37,883 shares of the company’s stock valued at $4,715,000 after buying an additional 1,750 shares during the period. Ontario Teachers Pension Plan Board grew its position in HCA Healthcare by 35.3% in the fourth quarter. Ontario Teachers Pension Plan Board now owns 84,882 shares of the company’s stock valued at $10,564,000 after acquiring an additional 22,160 shares in the last quarter. Commonwealth Equity Services LLC grew its position in HCA Healthcare by 8.7% in the fourth quarter. Commonwealth Equity Services LLC now owns 7,639 shares of the company’s stock valued at $950,000 after acquiring an additional 610 shares in the last quarter. Finally, Bank of Nova Scotia grew its position in HCA Healthcare by 505.0% in the fourth quarter. Bank of Nova Scotia now owns 557,426 shares of the company’s stock valued at $69,368,000 after acquiring an additional 465,293 shares in the last quarter. Hedge funds and other institutional investors own 72.85% of the company’s stock.
A number of research analysts have issued reports on the stock. Zacks Investment Research lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a report on Wednesday, November 14th. Oppenheimer upped their target price on shares of HCA Healthcare from $142.00 to $150.00 and gave the company an “outperform” rating in a report on Wednesday, January 30th. SunTrust Banks increased their price objective on shares of HCA Healthcare to $175.00 and gave the stock a “buy” rating in a report on Wednesday, January 30th. Leerink Swann increased their price objective on shares of HCA Healthcare from $160.00 to $175.00 and gave the stock an “outperform” rating in a report on Wednesday, January 30th. Finally, UBS Group initiated coverage on shares of HCA Healthcare in a report on Thursday, November 15th. They set a “buy” rating and a $162.00 price objective on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and eighteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $148.43.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Read More: How is an ETF different from a mutual fund?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.